The 2023 End ALS Calendar is here to bring fun and awareness into your day! All proceeds from the END ALS Calendar will go to ALS Therapy Development Institute to help them keep the fight against ALS moving forward.Click here to order your 2023 END ALS Calendar
Interdisciplinary research team using AI, engineering, and knowledge of disease complications to create “CART” STONY BROOK, NY, April 25, 2024 – The debilitating disease of…
The former N.F.L. player has been living with A.L.S. for more than a decade. Sharing “the most lacerating and vulnerable times” in “A Life Impossible”…
The FDA’s Center for Biologics Evaluation and Research is planning to release some crucial guidance soon for CRISPR and gene therapy developers on platform technologies,…
We are the world’s foremost drug discovery lab focused solely on ALS -ALS TDI
A nonprofit medical research foundation has launched a data portal designed to help spur scientific breakthroughs for the disease amyotrophic lateral sclerosis (ALS).
Researchers say it’s possible for nanoparticles to go through the digestive system and deliver medicine directly to the brain tissue.
“Mrs Zeza” expressed her firm conviction that her faith is stronger than any illness. Her testimony spread widely on the Vatican’s social networks, where her…
Affinia Therapeutics announced that new preclinical data on its novel AAV capsids for genetic cardiomyopathies and diseases of the central nervous system such as amyotrophic…
The Ministry of Justice officially confirmed the conclusions of the National Council of Notaries on full support for the evolutionary interpretation of the notarial law…
Small study suggested benefits for MS patients with chronic optic neuropathy
